PRODUCT GOVERNANCE. Under the requirements imposed by the CySEC in relation to Product Governance, the Company has determined and identified the Positive and Negative Target Market for each of the asset class of CFDs products offered. As part of the account opening procedure, you acknowledge that you should provide the necessary information to enable us to determine whether you fall within the identified Target Market of clients or not. Such information aims to evaluate whether your needs, characteristics and objectives are in line with the characteristics and risks of the complex and leveraged products offered by the Company. If you provide us with incorrect or incomplete information required under Product Governance regime, you will adversely affect our ability to carry out correctly our obligation and thus, you may be allowed to enter into Transactions in Financial Instruments that should not be marketed and offered to you.
PRODUCT GOVERNANCE. 5.3.1 The Broker adheres to the provisions of Applicable Law in relation to the product governance requirements and obtains required information from its clients in order to assess whether they fall in the positive target market or the negative target market prior to the provision of investment services. The aim of the aforesaid requirements is to evaluate whether Client’s needs, characteristics and objectives are consistent with the characteristics and risks of the products offered by the Broker.
PRODUCT GOVERNANCE. 27.1 Each party acknowledges that for the purposes of the PROD Rules, the Broker considers itself to be acting as a manufacturer of the Placing Shares in connection with the Placing.
27.2 Solely for the purposes of the UK Product Governance Requirements, the Broker acknowledges that it understands the responsibilities conferred upon it under the UK Product Governance Requirements relating to: (i) the target market for the Placing; (ii) the eligible distribution channels for dissemination of the Placing Shares, each as set out in the Placing Announcement; and (iii) the requirement to carry out a product approval process.
27.3 The Company shall, upon request, within a reasonable period provide to the Broker all such information within the Company’s possession as might reasonably be required by the Broker for the performance of its obligations under the PROD Rules, taking into account the proportionate application of the PROD Rules in the context of the Placing.
27.4 If the Broker enters into an arrangement with any Third Party Distributor in connection with the Placing which results in the Third Party Distributor becoming subject to any of the obligations applicable to distributors under the PROD Rules (or any equivalent rules in any EEA jurisdiction other than the UK) whether by way of operation of law, regulation or direction of a relevant regulator or as a result of contractual obligations (or any combination thereof) the Company agrees that it shall, upon request, provide all such information in the Company’s possession to the Third Party Distributor (or, where applicable, to the Broker to provide to the Third Party Distributor) as may reasonably be necessary for the performance by the Third Party Distributor of the Third Party Distributor’s obligations under the PROD Rules (or any equivalent rules of another EEA jurisdiction).
27.5 When providing any information for the purposes of this Clause 27, the Company shall expressly identify to the Broker any information that is not intended to be provided to prospective Placees.
PRODUCT GOVERNANCE. We are required, when manufacturing and/or distributing financial instruments to establish implement and maintain policies, procedures and measures to ensure that the manufacturing and/or distribution of financial instruments comply with the relevant product governance requirements under MIFID II, in a way so as to ensure that it is appropriate and proportionate taking into account the nature of the financial instrument the investment service(s) and the needs and circumstances f the Target Market for that financial instrument. The Company ensures that the design of the financial instrument including its features does not adversely affect its Clients or does not lead to problems with market integrity by enabling us to mitigate of its own risks or its exposures to the underlying assets of the product where We already hold the underlying assets on own account. The Company has a Product Governance Policy in place which ensures that We manufactures financial products targeting a particular group of Clients, so that the product meets their interests, needs and objectives (target market). The Company also identifies a group of end-Clients where these products may not be offered due to the Company’s assessment that the product does not meet their interests, needs and objectives (negative target market). Moreover, for each target market, the Company shall identify appropriate distribution channels/venues and media of marketing so that the product is offered to the target market (to a possible extent). The Company with this policy identifies information and practices that will enable to assess each individual end-Client’s compatibility with its products and comply with the normal MiFID II disclosure, suitability/appropriateness assessment, inducements, and conflicts of interest rules. The Company is required to assess the client for his compatibility with the designated target market. In this respect the Company must collect additional information exceeding the information collected during the assessment of Appropriateness Test or collected via the personal details of the client and Economic Profile. Therefore, the Company should also obtain information pertaining to the following: Ability to bear losses. Risk tolerance of the Client and compatibility with the risk/reward profile of the product. Client objectives and needs. The information may be obtained during the Client onboarding phase, or in case of new product launches prior to allowing the client to invest in...
PRODUCT GOVERNANCE. 18.1. Spectra Global has a policy in place to ensure that both Spectra Global’s respective responsibilities towards a client and its product governance obligations are met. Spectra Global is required to assess and define a target market for the investment products manufactured for, distributed or sold to you. Spectra Global’s role as a product distributor (seller) implies that Spectra Global will assess investments periodically and will share information on investments so that it can take any appropriate steps to improve outcomes for its clients (or the end client). Unless the Client tells Spectra Global otherwise, Spectra Global will assume that the Client is acting for his/her own account and not as a distributor for the purposes of these requirements.
18.2. When Spectra Global makes different products and services available to a Client, Spectra Global will do so in accordance with the Rules relating to the manufacturing and distribution of investment products. Spectra Global may not be able to make certain investment products available to you, depending on the Client’s classification and depending on the service, Spectra Global is providing to the Client.
PRODUCT GOVERNANCE. The Company has implemented its Product Governance Manual according to which it shall implement adequate product governance arrangements to ensure that the products and services of the Company are compatible with the needs, characteristics and objectives of an identified target market and that the intended distribution strategy is consistent with the identified target market. The Company under its capacity of both product manufacturer and distributor, will use the product manufacturer’s more general target market assessment (if any) as well as actual information and knowledge of its client base, to identify the target market and the distribution strategy of its products. The criteria to be considered include the following:
PRODUCT GOVERNANCE. Each of the Dealers agrees that a determination will be made in relation to each issue about whether, for the purpose of the MiFID Product Governance rules under EU Delegated Directive 2017/593 (the “MiFID Product Governance Rules”) and/or the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”), as applicable, any Dealer subscribing for any Notes is a manufacturer in respect of such Notes, but that, otherwise, neither the Arranger nor the Dealers nor any of their respective affiliates will be a manufacturer for the purpose of the MIFID Product Governance Rules and/or the UK MiFIR Product Governance Rules respectively.
PRODUCT GOVERNANCE. 32.1 The Company is required, when manufacturing and/or distributing financial instruments, to establish, implement and maintain procedures and measures to ensure that the manufacturing and/or distribution of financial instruments comply with the relevant product governance requirements, in a way that it is appropriate and proportionate taking into account the nature of the financial instrument, the investment service(s) and the needs of the Target Market of the product.
32.2 The Company ensures that the design of the financial instrument, including its features, does not adversely affect its end Clients or does not lead to problems with market integrity by enabling the Company to mitigate and/or dispose of its own risks or its exposure to the underlying assets of the product, where the Company already holds the underlying assets on own account.
32.3 In general, the Target Market compatible with the financial instruments manufactured and/or distributed by the Company is the group of clients with the following needs, characteristics and objectives: • Client categorisation: Retail client, or professional client or eligible counterparty. • Level of knowledge and/or experience: Sufficient with regard to the financial instruments manufactured and/or distributed by the Company. • Financial situation with a focus on the loss-bearing ability: Willing and able to bear total loss of his/her investment. • Risk tolerance and compatibility of the risk/reward profile of the financial instruments with the target market: The Summary Risk Indicator (“SRI”) score for the financial instruments manufactured and/or distributed by the Company is 7 out of 7. The SRI is a guide to the level of risk of financial instruments manufactured and/or distributed by the Company compared to other financial instruments. It shows how likely it is that these financial instruments will lose money because of movements in the markets. A SRI score of 7 out of 7 is the highest risk class. • Investment objectives and needs: In most cases, the investment objective is of speculative nature with a short-term investment horizon.
PRODUCT GOVERNANCE. Where applicable, we are subject to the ESMA product governance rules and regulations and will act in accordance with those rules and regulations in relation to the Financial Products which we transact with you. Where you have your own product governance obligations, you agree at all times to act in accordance with those obligations. In either of the foregoing instances you agree to provide us with such information as you are required to provide to us or as we require in order to meet our regulatory or contractual obligations.
PRODUCT GOVERNANCE. The Company and Allenby each acknowledge that for the purposes of PROD, Xxxxxxx considers itself to be acting as a manufacturer of the Placing Shares in connection with the Placing.
